Safety of biologic therapy in kidney and liver transplant recipients with systemic inflammatory diseases: a real-world study from Israel
This real-world cohort with 5-year follow-up since the post-SOT biologic initiation supported the feasibility of biologic therapy in SOT recipients with SIDs.
Authors
- Victoria Furer (ORCID: https://orcid.org/0000-0001-5193-4207)
- Liane Rabinowich (ORCID: https://orcid.org/0000-0002-0586-3046)
- Mark Berman (ORCID: https://orcid.org/0000-0001-9554-5553)
- Hagit Peleg
- Elisheva Pokroy‐Shapira (ORCID: https://orcid.org/0000-0002-4050-6642)
- Ayelet Grupper (ORCID: https://orcid.org/0000-0002-5590-9428)
- Omer Kersh
- Ori Elkayam (ORCID: https://orcid.org/0000-0002-1873-8930)
Institutions
- Tel Aviv University (IL)
- Tel Aviv Sourasky Medical Center (IL)
- Hadassah Medical Center (IL)
- Rabin Medical Center (IL)
Publication Details
- Journal
- Lara D. Veeken
- Published
- 2025-06-03
- DOI
- https://doi.org/10.1093/rheumatology/keaf303
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.00